Blackfield
Blackfield

7/2013
Blackfield Announces Fourth Major Pharmaceutical
Company Collaboration
>> read more

3/2013
Blackfield founder Prof. Roman Thomas receives the German Cancer
>> read more

3/2013
Blackfield: Mining cancer genomes. Emerging Company Profile in BioCentury
>> read more

WELCOME TO BLACKFIELD AG

Blackfield is a science-driven biotechnology company focusing on genome analytics, discovering modifiers of drug response and developing next-generation diagnostics. Applying our unique background in genomics, cancer medicine, and computational biology, we harness cancer genome information to support our clients in developing targeted cancer therapies. Blackfield’s business model is centered on highly customized collaborations to transfer science into the clinic.

Copyright © 2013 Blackfield AG   |   IMPRINT   |   PRIVACY POLICY